CLIA Approved Proficiency Testing
Closed Solicitation Posted
- Solicitation number
- 19-247-SOL-00001
- Agency
- Indian Health Service Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75H71219P00013 Federal contract award
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Not on record
- Place of performance
- Phoenix Indian Medical Center (Pimc) Laboratory Pathology Department Phoneix, Arizona 85016, United States
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
Amendment No. One (0001) is hereby issued to Solicitation No. 19-247-SOL-00001 to extend the closing date to 11/29/18 at 5:00 p.m., Phoenix, Arizona Time.
All Other Terms and Conditions Remain Unchanged..
Update #1 ·
The Indian Health Service (IHS), Phoenix Area Office (PAO), Division of Acquisition Management (DAM), located in Phoenix, Arizona, intends to solicit and award a sole source Purchase Order (PO) for Clinical Laboratory Improvement Amendments (CLIA) Approved Proficiency Testing (PT) Program and Laboratory Accreditation Program Services for the Phoenix Indian Medical Center (PIMC) Laboratory/Pathology Department. The contractor shall perform Proficiency Testing Samples for testing in Microbiology, Diagnostic Immunology, Chemistry, Hematology, Immunohematology, Point of Care Testing and Cytology. Also, shall provide a comprehensive proficiency testing samples that include Cytology, linear studies, competency assessments and quality assurance studies in to meet the accreditation. Contractor shall also provide College of American Pathologist (CAP) Surveys and CAP Accreditation Certification that is mandatory to the Indian Health Service, PIMC to improve patient safety and be in compliance with Joint Commission on Accreditation for Healthcare Organizations (JCAHO) and Centers for Medicare and Medicaid Services (CMS).
The North American Industry Classification System (NAICS) for this acquisition is 541380, Testing Laboratories: $15.00, unrestricted. Interested parties may identify their interest and capability to respond to the requirement. This notice is not a request for competitive proposals/quotes. However, the government will consider all responses received by 26 November 2018 by 1:30 P.M. Phoenix Arizona Time. A determination by the government not to compete this proposed PO based upon responses to this notice is solely within the discretion of the government. All responses received by 26 November 2018 by 1:30 P.M. Phoenix Arizona Time will be considered by the government. Responses shall be submitted electronically by the solicitation closing response date of 26 November 2018 by 1:30 P.M. Phoenix Arizona Time to Bradley.Platero@ihs.gov concerning this acquisition.
The Contractor shall provide CLIA Approved Proficiency Testing as follows:
1 Alpha-2 Macroglobulin
2 CAP/ACMG Alpha-1 Antitrypsin Genotyping
3 Automated Body Fluid
4 Automated Body Fluid
5 Automated Body Fluid
6 Accuracy Based Glucose, Insulin, and C-peptide
7 Accuracy-Based Lipids
8 ABO Subgroup Typing
9 Accuracy-Based Testosterone and Estradiol
10 Antibody Titer, Anti-A and Anti-D
11 Antibody Titer, Anti-A
12 Antibody Titer, Anti-D
13 Antibody Titer, Anti-B
14 Harmonized Thyroid
15 Accuracy-Based Urine
16 Accuracy-Based Vitamin D
17 Antichromatin Antibody
18 Angiotensin Converting Enzyme
19 Antiphospholipid Antibody
20 Aldolase
21 Antifungal Drugs Monitoring
22 Amniotic Fluid Leakage
23 1,5 Anhydroglucitol
24 Anti-HIV 1/2
25 Anti-HIV 1/2, Waived
26 Antihistone Antibody
27 CAP/AACC Whole Blood Alcohol/ Volatiles
28 CAP/AACC Serum Alcohol/ Volatiles
29 Antimullerian Hormone
30 Antinuclear Antibody
31 Autoimmune Gastritis Markers
32 CAP/ACMG Apolipoprotein E Genotyping
33 Antiphosphatidylserine Antibodies
34 Fetal Hemoglobin
35 Apixaban Anticoagulant Monitoring
36 Critical Care Blood Gas
37 Critical Care Blood Gas w/Chemistry
38 Quality Cross Check-Blood Gas w/Chemistry
39 Critical Care Blood Gas, i-STAT
40 Quality Cross Check-Blood Gas, i-STAT
41 Critical Care Blood Gas w/Chem, i-STAT
42 Quality Cross Check- Bld Gas w/Chemistry i-STAT
43 Quality Cross Check- Blood Gas
44 Antiribosomal P Antibody
45 AntiSperm Antibody
46 Anti-S. cerevisiae Antibody
47 Antistreptolysin O
48 Autopsy Pathology
49 Autopsy Pathology, Additional Pathologist
50 HLA-B27 Typing
51 B-ALL Minimal Residual Disease
52 Blood Cell ID, Photographs
53 Blood Cell ID, Limited
54 Bile Crystals
55 Blood Culture
56 Blood Culture, S. aureus
57 Bacterial Detection in Platelets, 2 Challenge
58 Bacterial Detection in Platelets, 5 Challenge
59 Bacterial Detection in Platelets, Rapid, 2 Challenge
60 Bacterial Detection in Platelets, Rapid, 5 Challenge
61 Body Fluid Crystals
62 CAP/ACMG Biochemical Genetics
63 CAP/ACMG Carnitine, Qual/Quant
64 Bone and Growth
65 CAP/AACC Blood Lead
66 Bone Marrow Cell Differential
67 1,25 Dihydroxy Vitamin D
68 Bone-Specific Alkaline Phosphatase
69 Vitamin A
70 Viatmin E
71 C-Telopeptide
72 N-Telopeptide
73 B-Type Natriuretic Peptides, 2 Challenge
74 B-Type Natriuretic Peptides, 5 Challenge
75 Quality Cross Check - BNP
76 B. pertussis/parapertussis, Molecular
77 Blood Parasite
78 BRAF
79 BRAF V600EIHC
80 CAP/ACMG BRCA 1/2 Sequencing
81 Bact Strain Typing, Staphylococcus
82 Bone and Mineral Metabolism, Urine
83 Bacterial Vaginosis
84 Chemistry - General, Limited
85 Chemistry - General, Comprehensive
86 Chemistry - General, Double Volume
87 Chemistry - Limited
88 Pseudocholinesterase
89 Campylobacter
90 Cord Blood Testing
91 Cyclic Citrullinated Peptide Antibody
92 Cadmium
93 CD30 Immunohistochemistry
94 C. diff, 2 Challenge
95 C. diff, 5 Challenge
96 Celiac Serology
97 Celiac Serology, Additional Volume
98 Cell-Free DNA
99 Coagulation, Basic
100 D-dimer/FDP
101 Coagulation, Extended
102 Coagulation-Extended, Additional Material
103 Coagulation, Limited
104 Quality Cross Check-Coagulation
105 Coagulation-Limited, Validated Material
106 Lupus Anticoagulant and Mixing Studies
107 Thrombophilia
108 von Willebrand Factor
109 Heparin
110 Heparin-Induced Thrombocytopenia
111 Heparin-Induced Thrombocytopenia
112 ADAMTS13
113 Heparin-Induced Thrombocytopenia
114 Total Hemolytic Complement
115 Human Papillomavirus, Digene
116 Human Papillomavirus, Mixed Media
117 Human Papillomavirus, SurePath
118 Human Papillomavirus, ThinPrep
119 Clinical Microscopy Miscellaneous Photopage
120 Urinalysis w/Body Fluid & Urine Sediment Photos
121 iChem Urinalysis w/Body Fluid & Urine Sediment Photos
122 Quality Cross Check-Urinalysis
123 CAP/ACMG Cardiomyopathy Sequencing Panel
124 Clinical Pathology Improvement Program
125 Clinical Pathology Improvement Program, Additional Participant
126 Carbopenem Resistant Organisms
127 C-Reactive Protein
128 Cardiac Markers
129 Cardiac Markers, Isoenzymes & Troponin I
130 Cryptococcal Antigen Detection
131 CAP/AACC Immunosuppressive Drugs
132 Activated Clotting Time
133 Activated Clotting Time
134 Quality Cross Check-ACT
135 Activated Clotting Time
136 Quality Cross Check-ACT
137 Activated Clotting Time
138 Quality Cross Check-ACT
139 Activated Clotting Time
140 Quality Cross Check-ACT
141 Cytokines
142 Quality Cross Check-ACT
143 CAP/ACMG Cytogenetics, Online Images
144 CAP/ACMG Cytogenetics, Booklet
145 CAP/ACMG Constitutional Microarray
146 CAP/ACMG Oncologic Microarray
147 CAP/ACMG FISH Constitutional/Hematologic Disorders
148 CAP/ACMG FISH, Paraffin-Embedded Tissue
149 CAP/ACMG FISH, Urothelial Carcinoma
150 CAP/ACMG FISH, Paraffin-Embedded Tissue
151 CAP/ACMG FISH, Paraffin-Embedded Tissue
152 CAP/ACMG FISH, Paraffin-Embedded Tissue
153 Cystatin C
154 Chemistry/Therapeutic Drug Monitoring
155 Chemistry/TDM, Triple Volume
156 Quality Cross Check - Chemistry/Therapeutic Drug Monitoring
157 Chemistry/TDM, Validated Material
158 Chemistry/TDM, Double Volume
159 Bacteriology
160 Throat Culture
161 Urine Culture
162 N. gonorrhoeae Culture
163 Bacteriology, Limited
164 Gram Stain
165 Rapid Group A Strep Antigen Detection
166 Throat/Urine Culture
167 Group B Strep Detection
168 Rapid Group A Strep Antigen Detection, Waived
169 HLA Disease Association-Drug Risk
170 HLA Disease Association-Drug Risk
171 Urine Drug Adulterant/Integrity
172 Direct Antiglobulin Testing
173 Dabigatran Anticoagulant Monitoring
174 Expanded Bacteriology
175 Drug-Facilitated Crime
176 Class I & II HLA Molecular Typing
177 Drug Monitoring for Pain Management
178 Digital Slide Program - Dermatopathology
179 Digital Slide Program - Dermatopathology, Additional Pathologist
180 Dipstick Confirmatory Testing
181 Ligand Assay - Testosterone, SHBG
182 Mycobacteriology
183 Mycobacteriology, Limited
184 EGFR
185 Expanded Virtual Peripheral Blood Smear
186 Eluate
187 Embryology
188 Erythropoietin
189 Erythrocyte Sedimentation Rate
190 Erythrocyte Sedimentation Rate
191 Erythrocyte Sedimentation Rate
192 Erythrocyte Sedimentation Rate
193 Ethanol Biomarkers
194 Expanded Transfusion Medicine Exercises
195 Everolimus
196 Electronic Crossmatch
197 Electronic Crossmatch, Automated
198 Mycology and Aerobic Actinomycetes
199 Yeast
200 Candida Culture
201 Fecal Calprotectin
202 Fecal Fat
203 Antifilamentous Actin IgG Antibody
204 Fetal Fibronectin
205 Galactomannan
206 Hematology Automated Differential Series
207 Hematology Automated Differential Blood Cell ID
208 Hematology Automated Differential Series
209 Hematology Automated Differential Blood Cell ID
210 Hematology Automated Differential Series
211 Hematology Automated Differential Blood Cell ID
212 Quality Cross Check - Hematology
213 Hematology Automated Differential Series
214 Hematology Automated Differential Blood Cell ID
215 Quality Cross Check - Hematology
216 Hematology Automated Differential Series
217 Hematology Automated Differential Blood Cell ID
218 Quality Cross Check-Hematology
219 Hematology Automated Differential Series
220 Hematology Automated Differential Blood Cell ID
221 Quality Cross Check-Hematology
222 Hematology Automated Differential Series
223 Hematology Automated Differential Blood Cell ID
224 Hematology Automated Differential Series
225 Hematology Automated Differential Blood Cell ID
226 Hematology Automated Differential Series
227 Hematology Automated Differential Blood Cell ID
228 Centrifugal Hematology
229 Flow Cytometry Combo (FL1/FL2)
230 Flow Cytometry, Lymphocyte Phenotype
231 Flow Cytometry, DNA Analysis
232 Flow Immunophen Leukemia/Lymphoma
233 Flow Cytometry, CD34+
234 Flow Cytometry, Interpretation Only
235 Fecal Lactoferrin
236 Body Fluid Chemistry
237 Body Fluid Chemistry 2
238 Quality Cross Check-Body Fluid Chemistry
239 Digital Slide Program in Fine-Needle Aspiration
240 Digital Slide Program in Fine-Needle Aspiration, Individual
241 Fine-Needle Aspiration Glass Slides, Laboratory
242 Fine-Needle Aspiration Glass Slides, Individual
243 Fondaparinux Anticoagulant Monitoring
244 RBC Folate
245 Second Trimester Maternal Screening
246 First Trimester Maternal Screen, Free Beta
247 First Trimester Maternal Screen, Total Beta
248 Second Trimester Maternal Screening, Additional Material
249 Forensic Pathology
250 Forensic Pathology, Additional Pathologist
251 Fungai Serology
252 Fungail Smear
253 Fructosamine
254 Forensic Toxicology, Criminalistics
255 Syphilis Serology
256 Glucose-6-Phosphate Dehydrogenase
257 Hemoglobin A1c, 3 Challenge
258 Hemoglobin A1c, 5 Challenge
259 Hemoglobin A1c, Internationl
260 Gastric HER2
261 Quality Cross Check-Hemoglobin A1c
262 Gastrointestinal Panel, 2 Challenge
263 Gastrointestinal Panel, 5 Challenge
264 Glioma
265 Gram-Negative Blood Culture Panel
266 Gastric Occult Blood
267 Gram-Positive Blood Culture Panel
268 Glycated Serum Albumin
269 Antimitochondrial M2 Antibody
270 Fetal Red Cell Detection
271 Hepatitis B Viral Load, 3 Challenge
272 Hepatitis B Viral Load, 5 Challenge
273 C. trachomatis Antigen (DFA) Detection
274 Herpes Simplex, Antigen Detection (DFA)
275 C. trachomatis Antigen Detection (EIA)
276 Herpes Simplex Virus, Culture
277 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA)
278 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA), Additional Material
279 C. trachomatis/N. gonorrhoeae with DNA
280 Waived Combination
281 Waived Combination
282 HCG, Serum
283 Hepatitis C Viral Load
284 Hematology - Basic
285 Hematology - Basic with Blood Cell ID
286 HER2 Immunohistochemistry
287 Hemocytometer Fluid Count
288 Hemocytometer Fluid count, Internationl
289 Hemoglobinopathy
290 CAP/ACMG Hemoglobinopathies Genotyping
291 HIV Genotyping
292 Homocysteine
293 Hematopathology Online Education
294 Hematopathology Online Education, Each Additional Participant
295 H.pylori Antigen, Stool
296 Human Papillomavirus
297 CAP/NSH Gastrointestinal Biopsy
298 CAP/NSH Dermatologic Biopsy
299 CAP/NSH Urogenital Biopsy
300 CAP/NSH Gynecologic Biopsy
301 CAP/NSH HistoQIP Immunohistochemistry
302 CAP/NSH HISTOQIP
303 CAP/NSH HISTOQIP Biopsy Series
304 CAP/NSH HistoQIP Mismatch Repair IHC
305 HQIP Non-small Cell Lung Carcinoma IHC
306 HQIP Whole Slide Image Quality Improvement Program
307 High Sensitivity C-Reactive Protein
308 Human Epididymis Protein 5
309 HIV Viral Load
310 Instrumentation
311 CAP/ACMG Inherited Cancer Sequencing Panel
312 Nucleic Acid Amplification, Viruses
313 Nucleic Acid Amplification, JC & BK
314 Nucleic Acid Amplification, Respiratory
315 Influenza A, Influenza B, and RSV by NAA
316 Meningitis/Encephalitis Panel
317 NAA, Organisms Without MTB
318 Nucleic Acid Amplification, Organisms
319 Infectious Disease, Respiratory Panel
320 Interfering Substances
321 Immunology - General
322 IGHV Mutation Analysis
323 Immunology - General, Double Volume
324 Immunology - Comprehensive
325 Infectious Mononucleosis
326 CAP/ACMG Mitochondrial DNA Deletion Syndrome
327 CAP/ACMG MCAD
328 CAP/ACMG Mitochondrial Cytopathies
329 Infectious Mononucleosis, Waived
330 India Ink
331 Insulin, Gastrin, C-Peptide, and PTH
332 In Situ Hybridization
333 In Situ Hybridization, HER2 (ERBB2)
334 Transfusion Medicine - Comprehensive
335 Transfusion Medicine - Limited
336 Transfusion Medicine - Automated
337 Transfusion Medicine - Automated Educational Challenge
338 Quality Cross Check - Transfusion Medicine
339 Transfusion Medicine - Educational Challenge
340 Ligand - General
341 Ligand - Limited
342 Ketones
343 KIT/PDGFRA
344 Ligand - General, Double Volume
345 KRAS
346 Kidney Stone Assessment
347 Ligand Assay - General, Validated Material
348 Legionella Antigen Detection
349 Lamellar Body Count
350 Chemistry Limited, Waived
351 Liver-Kidney Microsomal Antibody
352 Chemistry, Lipid, Enzyme Calibration Verification/ Linearity
353 chem CVL Beck (Except AU), Vitros Calibration Verification/ Linearity
354 Therapeutic Drug Monitoring Calibration Verification/ Linearity
355 Ligand Assay Calibration Verification/ Linearity
356 Ligand Assay, Siemens Calibration Verification/ Linearity
357 Urine Chemistry Calibration Verification/ Linearity
358 Immunology Calibration Verification/ Linearity
359 Reproductive Endocrinology Calibration Verification/ Linearity
360 Hematology Calibration Verification/ Linearity
361 Serum Ethanol Calibration Verification/ Linearity
362 C-Reactive Protein Calibration Verification/ Linearity
363 C-Reactive Protein, Extended Calibration Verification/ Linearity
364 Blood Gas Calibration Verification/ Linearity
365 Blood Gas /Critical Care Calibration Verification/ Linearity
366 Hemoglobin A, Accuracy Calibration Verification/ Linearity
367 Homocysteine Calibration Verification/ Linearity
368 Whole Blood Glucose Calibration Verification/ Linearity
369 Reticulocyte Calibration Verification/ Linearity
370 Reticulocyte Calibration Verification/ Linearity
371 Urine Albumin Calibration Verification/ Linearity
372 High-Sensitivity CRP Calibration Verification/ Linearity
373 Flow Cytometry Calibration Verification/ Linearity
374 Prostate-Specific Antigen Calibration Verification/ Linearity
375 Creatinine Accuracy Calibration Verification/ Linearity
376 Troponin I Calibration Verification/ Linearity
377 Troponin T Calibration Verification/ Linearity
378 B-Type Natriuretic Peptide Calibration Verification/ Linearity
379 Immunosuppressive Drugs Calibration Verification/Linearity
380 Ammonia Calibration Verification/ Linearity
381 Serum Myoglobin Calibration Verification/Linearity
382 Tumor Markers Calibration Verification/ Linearity
383 Thrombophilia Calibration Verification/ Linearity
384 Heparin Calibration Verification/Linearity
385 von Willebrand Factor Antigen Calibration Verification/Linearity
386 CMV Viral Load Calibration Verification/Linearity
387 HIV Viral Load Calibration Verification/Linearity
388 Vitamin D Calibration Verification/Linearity
389 Procalcitonin Calibration Verification/Linearity
390 D-Dimer Calibration Verification/Linearity
391 Lamellar Body Count Calibration Verification/Linearity
392 Fibrinogen Calibration Verification/ Linearity
393 HCV Viral Load Calibration Verification/ Linearity
394 C-Peptide/Insulin Calibration Verification/ Linearity
395 Lipoprotein Electrophoresis
396 Laboratory Preparedness Exercise
397 Cerebrospinal Fluid Chemistry
398 Micro Bench Tools Competency
399 Microbiology - Combination w/GC
400 Microbiology - Combination
401 Urine Colony Count
402 Urine Colony Count Combination
403 Throat & Urine Cult/Rapid Strep A AG Det
404 Monitoring Engraftment
405 CAP/ACMG Molecular Genetics
406 CAP/ACMG Molecular Genetics
407 CAP/ACMG Molecular Genetics
408 CAP/ACMG Molecular Genetics
409 CAP/ACMG Cystic Fibrosis
410 MHO, Lymphoma
411 MHO1, Lymphoma, Double Volume
412 MHO2, Leukemia Only
413 MHO3, Leukemia Only, Double Volume
414 DNA Extraction & Amplification FFPE
415 Immunohistochemistry
416 MMA and Active B13
417 DNA Mismatch Repair
418 Mycophenolic Acid
419 Minimal Residual Disease, BCR/ABL 1 p210
420 Minimal Residual Disease, BCR/ABL 1 p190
421 Minimal Residual Disease, PML/RARA
422 Methicillin Resistant S. aureus, 2 Challenge
423 MRSA Screen, Molecular, 2 Challenge
424 Methicillin Resistant S. aureus, 5 Challenge
425 MRSA Screen, Molecular, 5 Challenge
426 Microsatellite Instability
427 Molecular MTB ID & Resistance Detection
428 Multigene Tumor Panel
429 Cerebrospinal Fluid, Validated Material
430 Molecular Vaginal Panel
431 HLA XMatch, Antibody Screen & ID (Class I)
432 HLA XMatch, Antibody Screen & ID (Class I)
433 HLA Antibody Screen & ID (Class I)
434 HLA XMatch, Antibody Screen & ID (Class II)
435 HLA Xmatch, Antibody Screen & ID (Class II)
436 HLA Antibody Screen & ID (Class II)
437 MX1 / MX2 - MX1B/MX2B Combination, Class I & II
438 MX1 / MX2 - MX1C/MX2C Combination, Class I & II
439 Myoglobin, Urine
440 Urine Chemistry, Special
441 Nucleic Acid Testing
442 Neonatal Bilirubin, 5 Challenge
443 Neonatal Bilirubin, 2 Challenge
444 Neoplastic Cellularity
445 Interlab Comp Non-Gyn Cytology, Laboratory
446 Interlab Comp Non-Gyn Cytology, Individual
447 Next-Generation Sequencing - Germline
448 NGS Bioinformatics forllumina
449 NGS Bioinformatics for Ion Torrent
450 NGS Bioinformatics Somatic, Validated Material
451 NGS Undiagnosed Disorders - Exome
452 NGS Hematologic Malignancies
453 NGS Solid Tumor
454 Noninvasive Prenatal Testing
455 Novel Opioids and Benzodiazepines
456 Neuropathology Program
457 Neuropathology Program, Additional Pathologist
458 Nicotine and Tobacco Alkaloids
459 Urine Chemistry - Special, Double Volume
460 Occult Blood
461 Quality Cross Check-Occult Blood
462 Oral Fluid for Drugs of Abuse
463 CSF Chemistry w/Oligoclonal Bands
464 Parasitology
465 P16 Immunohistochemistry Tissue Microarray
466 Parasite, Fecal Suspension, Immunoassay
467 Parasite, Fecal Suspension, PVA, Immunoassay
468 Parasitology, Giardia/Crypto Immunoassay
469 PAP PT and Education Programs
470 Parentage/Relationship Test - Filter Paper
471 Plasma Cardiac Markers International
472 Plasma Cardiac Markers
473 Plasma Cardiac Markers, Double Volume
474 Flow Cytometry - Plasma Cell Neoplasms
475 Pneumocystis, Calcofluor White Stain
476 Pneumocystis, DFA Stain
477 Pneumocystis, GMS Stain
478 Procalcitonin
479 PD-L1
480 Expanded parasitology
481 Platelet Aggregation
482 Platelet Function
483 Pharmacogenetics
484 IL28B Genotyping
485 HLA Drug Hypersensitivity
486 DPYD, TPMT, UGT1A1 Genotyping
487 Plasma Hemoglobin
488 Drug-Specific Platelet Aggregation
489 Drug-Specific Platelet Aggregation, Double Volume
490 Performance Improvement Program in Surgical Pathology
491 Performance Improvement Program in Surgical Pathology, Additional Pathologist
492 Online Performance Improvement Program, Surgical Pathology
493 Online Performance Improvement Program, Surgical Pathology, Additional Pathologist
494 Lipoprotein-Associated Phospholipase A2
495 Platelet Mapping
496 CD117, IHC Tissue Microarray
497 ER/PGR, IHC Tissue Microarray
498 CD20, IHC Tissue Microarray
499 IHC Tissue Microarray Series
500 Anaplastic Lymphoma Kinase IHC TMA
501 PNA for FISH for Staphylococcus
502 PNA for FISH for Yeast
503 Flow PNH Immunophenotyping
504 POC hCG Competency
505 POC Glucose Competency
506 POC Urine Dipstick Competency
507 POC Strep Screen Competency
508 POC PT/INR, CoaguChek XS+ Competency
509 POC Waived Glucose & Hemoglobin Competency
510 POC Influenza AB Antigen Detect Competency
511 POC Fecal Occult Blood Competency
512 POC Blood Gases Competency
513 POC Blood Gases, i-STAT Competency
514 POC Plasma Cardiac Markers Competency
515 POC Medtronic ACT/ACT, i-STAT Competency
516 POC Hemochron Jr IL GEM ACT-LR Competency
517 POC Hemochron Jr Signature IL GEM Competency
518 Platelet Serology
519 Quality Cross Check-Parathyroid Hormone
520 Semen Analysis
521 Postvasectomy Sperm Count - Automated
522 M. tuberculosis-Stimulated Infection Detection
523 Technical Staffing Ratios
524 Opioid Drug Testing Stewardship
525 Expression Rates in Invasive Breast Carcinoma
526 Impact of Pathologist Review of Peripheral Blood Smears
527 Four Q-PROBES Studies
528 Patient Identification Accuracy
529 Blood Culture Contamination
530 Laboratory Specimen Acceptability
531 Blood Product Wastage
532 Gynecologic Cytology Outcomes
533 Outpatient Satisfaction with Phlebotomy Service
534 Stat Test Turnaround Time Outliers
535 Critical Values Reporting
536 Troponin Turnaround Times
537 Corrected Results
538 Outpatient Order Entry Errors
539 Clinical Pathology Monitors
540 CP/AP QTRACKS Monitors
541 Trace Metals
542 Red Blood Cell Antigen Genotyping
543 Renin and Aldosterone
544 Red Blood Cell Antigen Typing
545 Rheumatic Disease Special Serologies
546 CAP/ACMG Rett Syndrome (MECP2)
547 Rheumatoid Factor
548 Rare Flow Antigen Validation, CD1A
549 Rare Flow Antigen Validation, CD103
550 Rheumatoid Factor, Double Volume
551 Anti-HCV, Rapid Methods, Waived
552 Rapid Malaria
553 Fusion RNA
554 Rupture of Fetal Membranes
555 Reticulocyte
556 Reticulocyte
557 Reticulocyte
558 Quality Cross Check-Reticulocyte
559 Reticulocyte
560 Quality Cross Check-Reticulocyte
561 Quality Cross Check-Reticulocyte
562 Rubella
563 Rubella, Double Volume
564 Rapid Urease
565 Rivaroxaban Anticoagulant Monitoring
566 Rapid Total Whole Blood Cell Count
567 Immunology - Special
568 Immunology - Special, Limited
569 Immunology - Special, H. pylori IgG
570 Salivary Cortisol
571 Sarcoma Translocation
572 S. pneumoniae Antigen Detection
573 Sperm Count
574 Automated Sperm Count
575 Synthetic Cannabinoid/Designer Drugs
576 Urine Hemosiderin, Prussian Blue
577 Urine Eosinophils, Wright Stain
578 Serum Carryover
579 Stem Cell Processing
580 Sickle Cell Screening
581 Serum Drug Screening
582 Diagnostic Allergy
583 CAP/ACMG DNA Sequencing Interpretation
584 CAP/ACMG DNA Sequencing Interpretation
585 Serum Free Light Chains
586 Sperm Morphology
587 Sperm Morphology on CD
588 Sperm Viability on CD
589 Sperm Count and Motility on CD
590 Blood Oximetry
591 Quality Cross Check - Blood Oximetry
592 Stool Pathogens
593 Norovirus
594 Protein Electrophoresis
595 Stool Pathogen, without Shigatoxin
596 Shiga Toxin
597 Soluble Transferrin Receptor
598 Sperm Viability
599 Sweat Analysis
600 Sweat Analysis
601 Sweat Analysis
602 Sweat Analysis
603 Toxicology
604 Total Bile Acids
605 Viscoelastometry
606 Blood Cannabinoids
607 Touch Imprint/Crush Preparation
608 Touch Imprint/Crush Prep, Additional Participant
609 Tumor Markers
610 Transfusion Medicine Comprehensive - Competency Assessment
611 Direct Antiglobulin Test - Competency Assessment
612 Eluate Competency Assessment
613 Fetal Red Cell Quantitation - Competency Assessment
614 Ticks, Mites, and Other Arthropods
615 Trace Metals, Urine
616 Trace Metals, Whole Blood
617 Tumor Markers, Double Volume
618 Troponin T, 2 Challenge
619 Troponin T, 5 Challenge
620 CAP/ACMG Thromophilia Mutations
621 Transfusion Related Cell Count
622 Tick Transmitted Disease
623 T. vaginalis, Molecular
624 Urine Chemistry - General
625 Automated Urine Microscopy
626 Automated Urine Microscopy
627 Urine Bence Jones Protein
628 CAP/AACC Forensic Urine Drug Test, Confirmatory
629 CAP/AACC Urine Drug Testing, Screening
630 CAP/AACC Urine Drug Testing, Screening, Ltd
631 Urine Drug Testing, Screen, Validated Material
632 Urine hCG
633 Urine Albumin and Creatinine, Semiquant
634 Porphobilinogen, Urine
635 Urine Crystals
636 Urine Toxicology
637 Urine Toxicology Carryover
638 Urine Chemistry - General, Validated Material
639 Viscosity
640 Vector-Borne Disease - Molecular
641 Virtual Body Fluid
642 Virtual Biopsy Program
643 Virtual Biopsy Program, Additional Pathologist
644 Vitreous Fluid, Postmortem
645 Virtual Gram Stain Basic Competency
646 Virtual Gram Stain Advanced Competency
647 Variant Interpretation Only
648 Variant Interpretation Only, Additional Participant
649 25-OH Vitamin D, Total
650 BK, CMV, and EBV Viral Load
651 Viral Load
652 Viral Markers - Series 1
653 Viral Markers - Series 2
654 Viral Markers - Series 3
655 Viral Markers - Series 4
656 Viral Markers - Series 5
657 Viral Markers - Series 6
658 Viral Markers - Series 6, Additional Material
659 Virtual Peripheral Blood Smear
660 Virology Culture
661 Virology Antigen Detection (DFA)
662 Infectious Disease Serology
663 Infectious Disease Serology, Mumps
664 Virology Antigen Detection (Non-DFA)
665 Vancomycin-Resistant Enterococcus
666 Vaginitis Screen Antigen Detection
667 Vaginitis Screen, T. Vaginalis
668 Vaginitis Screen, Virtual Gram Stain
669 Whole Blood Creatinine
670 Quality Cross Check-Whole Blood Glucose
671 Worm Identification
672 Whole Blood PT/INR, I-STAT
673 Whole Blood Citrated PT Hemochron/ IL GEM
674 Whole Blood Non-Citrated PT Hemochron/ IL GEM
675 Whole Blood Coagulation - CoaguChek, XS Plus
676 Whole Blood Coagulation - CoaguChek XS System
677 Ligand - Special
678 Ligand - Special, Validated Material
679 Ligand - Special, Additional Volume
680 TDM - General, Comprehensive
681 ZAP-70/CD49D Analysis by Flow Cytometry
682 Therapeutic Drug Monitoring - Extended
683 Therapeutic Drug Monitoring - Special
684 PAP PT ThinPrep W/ED Series 1, INDV
685 PAP PT ThinPrep W/ED Series 1
686 CAP Generic Survey Binder
687 ESTIMATED FUEL SURCHARGE
.
Attachments
| File | Type | Posted |
|---|---|---|
| Attachment_B_-_Scope_of_Work.pdf | ||
| Attachment_C_-_Provisions_&_Clauses.pdf | ||
| Attachment_A_-_SF1449.pdf | ||
| Attachment_D_-_Price_Schedule.xlsx | XLSX spreadsheet | |
| Attachment_E_-_Instruction_of_Offerors.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity